Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Trial Profile

Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2013

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Facial-wrinkles
  • Focus Therapeutic Use
  • Sponsors Revance Therapeutics
  • Most Recent Events

    • 27 Dec 2013 According to ClinicalTrials.gov record trial status changed from active, no longer recruiting to completed.
    • 04 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top